To the full analysis
International Flavors & Fragrances stock: growth
IFFInternational Flavors & Fragrances reported $10.89B in revenue for fiscal 2025, down 5.2% on the prior year, up 16.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9.1%
per year from 2006 to 2025, per share 3.3%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
0.7%
per year from 2006 to 2025, per share −4.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 16.5% | 13.7% | 9.1% |
| Revenue per share | −1.3% | 1.2% | 3.3% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −13.3% | −3.5% | 0.7% |
| Free cash flow per share | −26.5% | −14.1% | −4.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.1B | $226.5M | $223.34M |
| 2007 | $2.28B | $247.13M | $248.45M |
| 2008 | $2.39B | $229.63M | $135.22M |
| 2009 | $2.33B | $195.53M | $224.82M |
| 2010 | $2.62B | $263.56M | $208.84M |
| 2011 | $2.79B | $266.87M | $61.73M |
| 2012 | $2.82B | $254.13M | $197.66M |
| 2013 | $2.95B | $353.54M | $273.41M |
| 2014 | $3.09B | $414.54M | $375.21M |
| 2015 | $3.02B | $419.25M | $366.29M |
| 2016 | $3.12B | $405.03M | $423.73M |
| 2017 | $3.4B | $295.67M | $261.78M |
| 2018 | $3.98B | $334.45M | $264.16M |
| 2019 | $5.14B | $454M | $457M |
| 2020 | $5.08B | $365M | $522M |
| 2021 | $11.66B | $268M | $1.04B |
| 2022 | $12.44B | −$1.87B | −$109M |
| 2023 | $11.48B | −$2.57B | $936M |
| 2024 | $11.48B | $243M | $602M |
| 2025 | $10.89B | −$361M | $256M |
Revenue by segment
How International Flavors & Fragrances Inc. makes its money and how that has shifted. Names are as the company reports them.
- Food Ingredients$3.3B30%
- Taste$2.5B23%
- Scent$2.5B23%
- Health & Biosciences$2.3B21%
- Pharma Solutions$369.0M3%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Food Ingredients | $3.28B | 30.1% |
| Taste | $2.48B | 22.8% |
| Scent | $2.48B | 22.8% |
| Health & Biosciences | $2.28B | 21% |
| Pharma Solutions | $369M | 3.4% |
| Total revenue | $10.89B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 5 Nov 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.